Oncogenic Ppm1d mutations deregulate the p53 pathway in primary mouse gliomas
Vennesa Valentine, Adam Groth, Joshua Tolliver…·Zachary J. Reitman
This study develops a mouse model of Ppm1d mutations in gliomas, showing they deregulate the p53 pathway, promote gliomagenesis, and increase radiosensitivity and PARP inhibitor vulnerability.